Anemia in CKD patients is a multifactorial process associated with a relative erythropoietin (EPO) deficiency, uremic-induced inhibition of erythropoiesis, shortened erythrocyte survival, and disordered iron homeostasis [2]. The gene discussed is EPO; the disease is hyperinsulinemic hypoglycemia, familial, 4.